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Background: Vitamin D deficiency is associated with osteoporotic fractures, such as hip 
fracture. Sun exposure, the natural source of vitamin D, is the main risk factor for basal cell 
carcinoma (BCC) and squamous cell carcinoma (SCC). In this study, we examined the association 
between a history of hip fracture and risk of BCC and SCC.
Methods: We conducted a population-based case-controlled study using data on BCC and SCC 
cases registered in the Danish Cancer Registry from 1990–2005. For each case, we selected 
five population controls matched by age and gender. We used conditional logistic regression 
to compute odds ratios (OR) and 95% confidence intervals (CI), while adjusting for chronic 
diseases and socioeconomic status.
Results: A history of hip fracture was associated with a decreased risk of BCC (OR 0.90, 95% 
CI 0.85–0.94), which was most pronounced in cases of tumors on the trunk, extremities, or at 
multiple sites. We found no association for SCC (OR 1.07, 95% CI 0.98–1.17).
Conclusion: Our study showed an inverse association between history of hip fracture and risk 
of BCC, but not of SCC. Sun exposure, resulting in vitamin D synthesis, may explain the link 
between the two diseases.
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Introduction
Vitamin D is essential for bone mineralization because of its role in maintaining 
adequate levels of serum calcium and phosphorus.1 Vitamin D deficiency precipitates 
and exacerbates osteoporosis and causes muscle weakness, factors which enhance the 
risk of fractures.2–5 In humans, vitamin D is mainly obtained through the skin being 
exposed to direct sunlight.6 Sunlight also causes oncogenic mutations in the skin leading 
to skin cancers, including basal cell carcinoma (BCC), squamous cell carcinoma (SCC), 
and malignant melanoma.7 Intermittent high sun exposure is the main risk factor for 
BCC,8,9 while risk factors for SCC include cumulative sun exposure.9–14 Other risk 
factors include immunosuppressive treatments, cutaneous viral carcinogens, chemical 
carcinogens, ionizing radiation, phototherapy, and smoking.9–14 The reaction of the skin 
to sun exposure also impacts skin cancer risk. Skin that burns easily or tans poorly is 
also a risk factor.15–17 Two previous Danish studies have reported different mortality 
patterns among BCC and SCC patients, suggesting differences in the clinical courses 
of the two diseases.18,19
Few data exist on the link between fractures and nonmelanoma skin cancer. In a 
large case-controlled study in several European countries (Mediterranean Osteoporosis 
Study), higher self-reported past sunlight exposure was associated with a lower risk 
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of hip fracture.20,21 In a nested case-controlled study, serum 
25(OH)D levels of 220 BCC patients and 220 controls were 
measured.22 Blood samples were collected 4–21 years before 
the development of BCC diagnosis/corresponding date for 
the controls. The findings suggested that higher prediagnostic 
serum 25(OH)D levels may be associated with increased 
risk of subsequent BCC.22 In contrast, another nested case-
controlled study of elderly men (.65 years) showed an 
inverse association between serum 25(OH)D levels and 
self-reported nonmelanoma skin cancer.23 Serum 25(OH)D 
levels was measured at baseline. Information of a history of 
nonmelanoma skin cancer was collected at baseline and at a 
five-year follow-up visit.
A Tasmanian study investigated the association between 
nonmelanoma skin cancer and risk of hip fracture, using 
nonmelanoma skin cancer as a biomarker for sun exposure.24 
They reported a 31% lower incidence of prior nonmelanoma 
skin cancer in a cohort of fracture patients using gender-, 
age-, and calendar year-specific cancer incidence rates in 
southern Tasmania as reference.24 However, the study did 
not consider important potential confounding factors, such 
as chronic diseases and socioeconomic status. These are both 
factors that have importance for nonmelanoma skin cancer 
risk.14,25 Therefore, we examined the association between a 
history of hip fracture and subsequent BCC and SCC in a 
population-based case-controlled study while accounting for 
detailed information on chronic diseases and socioeconomic 
status.
Methods
We conducted this nationwide, population-based, case-
  control study based on the entire Danish population 
(5.3 million) using Danish medical registries. All residents 
of Denmark are registered in the Danish Civil Registration 
System with a unique civil registration number assigned at 
birth or upon immigration. Information on changes in vital 
status, such as emigration and death, are registered in the 
Civil Registration System and the civil registration number 
can be used to link data on individuals in different Danish 
registries.26
nonmelanoma skin cancer cases
We used the Danish Cancer Registry to identify all patients 
with a diagnosis of BCC or SCC recorded between 
  January 1, 1990 and December 31, 2005. The Danish 
Cancer   Registry contains information on primary cases of 
cancer on a nationwide basis since 1943, and its data has 
been shown to be 95% complete with a validity of 98%.27 
The Danish Cancer Registry files include information on 
cancer type, site, morphology, and cancer history. Tumors 
are coded according to the 10th revision of the Interna-
tional Classification of Diseases (ICD-10) since 1978. In 
  addition, tumors are coded according to the third version 
of the   International Classification of Diseases for   Oncology 
(ICD-O-3), which includes a four-digit code for tumor 
topography and morphology.
We first identified patients with nonmelanoma skin cancer 
using ICD-10 codes C44.0–C44.9, covering all nonmelanoma 
skin cancer diagnoses. We then identified BCC patients 
using the ICD-O-3 morphology codes 80903, 80913, 80923, 
80933, 80943, and 80953. We identified SCC patients using 
ICD-O-3 codes 80513, 80523, 80703 (SCC), 80713, 80743, 
80753, and 80763. BCC patients, who were diagnosed with 
SCC after or on the date of their primary BCC diagnosis, 
were grouped with SCC patients. We excluded patients 
younger than 40 years (BCC, n = 2789; SCC, n = 74), because 
hip fracture in this age group is a rare event and seldom of 
osteoporotic origin.28
Based on ICD-10 codes recorded in the Danish Cancer 
Registry, we divided BCC and SCC patients into three groups 
according to tumor location, which is a marker for the amount 
of body surface exposed to sunlight. Tumors in the head and 
neck area are regarded as a marker of cumulative sunlight 
exposure.29,30 However, the head and neck comprise only a 
small part of the whole body surface, and exposure of these 
areas alone to the sun results in limited vitamin D synthesis.31 
In contrast, the trunk and extremities represent a larger body 
surface area and their exposure to sunlight results in much 
more vitamin D synthesis.31 We defined head and neck tumors 
using ICD-10 codes C44.0–C44.4, tumors on the body (trunk 
and extremities) using ICD-10 codes C44.5–C44.7, and 
tumors at multiple sites using ICD-10 code C44.8.
general population controls
Approximately five population controls for each BCC or SCC 
case were individually matched on age, and gender, based on 
risk-set sampling.32 A total of 404,919 population controls 
were extracted from the Civil Registration System.33
History of hip fracture
Data on hip fracture were obtained from the Danish National 
Patient Registry. In Denmark, the National Health Service 
provides tax-supported free medical care for all citizens. 
The Danish National Patient Registry contains data on dis-
charges from all nonpsychiatric hospitals since 1977 and on 
emergency department and outpatient clinic visits since 1995. 
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
286
Lamberg et alClinical Epidemiology 2011:3
Its records include patients’ civil registration number, dates 
of admission and discharge, and up to 20 discharge diagnoses 
coded by physicians in accordance with ICD-8 until the end 
of 1993 and the ICD-10 thereafter. We identified hip fractures 
using the ICD-8 codes 820.00 (fracture of the neck of femur) 
and 820.01 (pertrochanteric fracture) and the corresponding 
ICD-10 codes, ie, S72.0 and S72.1, occurring before the 
diagnosis date or index date for controls.
Data on chronic diseases
Because a number of chronic diseases may increase the risk 
of hip fracture and may be associated with   nonmelanoma 
skin cancer, we obtained data from the Danish National 
Patient Registry on any prior hospital diagnosis since 
1977 of a nondiabetic endocrine disorder, diabetes, 
gastrointestinal disorder, leukemia and lymphoma, connec-
tive tissue disease, alcohol abuse, chronic obstructive pulmo-
nary disease, neurological disorders leading to increased risk 
of falls, dementia,   congestive heart failure, cerebrovascular 
  disease, solid cancer, malignant melanoma, and chronic renal 
  disease occurring before the diagnosis date or index date for 
controls.14,34 Both inpatient and outpatient diagnoses were 
included. (For details on ICD codes, see Appendix.)
Data on socioeconomic status
A database maintained by Statistics Denmark since 1980 
provides detailed data on socioeconomic status for the entire 
Danish population.35 We used four variables to classify 
socioeconomic status among BCC and SCC patients and 
their population controls, ie, occupational level, educational 
attainment, income, and marital status.36 Occupational level 
and educational attainment were divided in levels in order 
to classify socioeconomic status (Table 1).36 Income-based 
socioeconomic status was divided into four groups according 
to quartiles of national average income for a given year. 
The quartiles were calculated based on both cases and 
controls of the total population before excluding persons 
aged less than 40 years. Marital status was categorized as 
married/cohabiting, divorced/widower, and never married 
on the diagnosis or index date. Information on marital status 
and education was obtained at the diagnosis or index date. 
Occupational group and income variables are based on 
employment status, and nonmelanoma skin cancer patients 
tend to be elderly and retired when they are diagnosed. 
Information on occupational level and income was therefore 
obtained for the period 10 years before diagnosis/index 
date to a more accurate picture of overall occupational and 
income status.36
Information on educational level was missing for a 
great number of people (32% of BCC patients and their 
population controls, and 53% of SCC patients and their 
population controls). This is due to the fact that most BCC 
and SCC patients were over 50 years of age on the date of 
diagnosis, and because information on educational level is 
only available from 1980 onwards (ie, the year the database 
was established in Statistics Denmark).
statistical analysis
We used conditional logistic regression to compute odds 
ratios (OR) and 95% confidence interval (CI) for the 
relation between a history of hip fracture and BCC and 
SCC, respectively, while adjusting for chronic diseases and 
socioeconomic status. We conducted analyses both with 
and without educational attainment, and found that this 
variable did not change our estimates. Thus, we excluded 
education in the final analyses. We used conditional logistic 
regression to compute OR according to tumor location (ie, 
head and neck, trunk/extremities, and multiple sites). Because 
we used risk-set sampling, the estimated exposure OR in a 
case-control design is an unbiased estimate of the incidence 
rate ratio.37 We repeated the analyses stratified by age and 
gender, in order to assess the effect of these variables. All 
statistical analyses were performed using STATA®   software 
(version 11.1). The study was approved by the Danish 
  Registry Board.
Results
Descriptive data
Using the Danish Cancer Registry, we identified 69,506 BCC 
patients and 11,526 SCC patients who were over the age 
of 40 years and who were recorded in the registry between 
January 1, 1990 and December 31, 2005. The median age 
of BCC patients was 69 (range 40–104) years. A total of 
33,297 (48%) of BCC patients had head and neck tumors, 
15,362 (22%) had tumors located on the trunk and extremi-
ties, and 19,909 (29%) had tumors located at multiple sites. 
BCC patients with tumors located in the head and neck 
region were in general older than patients with tumors on 
the trunk/extremities and at multiple sites (data not shown). 
BCC patients had a similar prevalence of chronic diseases, 
but a higher socioeconomic status level than their population 
controls (Tables 1 and 2). The median age of SCC patients 
was 78 years (40–106) years. Among SCC patients, 6570 
(57%) had tumors in the head and neck region, 2782 (24%) 
had tumors on the trunk or extremities, and 1963 (17%) had 
tumors at multiple sites. SCC patients with tumors located 
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in the head and neck region were generally older than 
patients with tumors on the trunk/extremities and at multiple 
sites (data not shown). SCC patients and their population 
controls had similar socioeconomic status levels (Table 1). 
SCC patients had a higher prevalence of chronic diseases 
  compared with their population controls (Table 2).
History of hip fracture and risk of BCC
The overall number of patients with a history of hip fracture 
was 1930 (2.8%) among BCC patients and 10,914 (3.1%) 
among controls, corresponding to an adjusted OR of 0.90 
(95% CI 0.85–0.94) for BCC among patients with a history 
of hip fracture. We found that the prevalence of a history of 
hip fracture was dependent on tumor location (P , 0.01). 
Stratified by location, the number of patients with a history 
of hip fracture was 1158 (3.5%) among BCC patients with 
head and neck tumors and 6044 (3.6%) among their controls, 
corresponding to an adjusted OR of 0.96 (95% CI 0.89–1.02). 
Among patients with trunk/extremities tumors and their 
controls, the numbers were 334 (2.2%) and 2019 (2.6%), 
respectively, corresponding to an adjusted OR of 0.85 (95% 
CI 0.75–0.96). Among patients with tumors at multiple sites 
and among their controls the numbers were 404 (2.0%) and 
2684 (2.7%), respectively, corresponding to an adjusted OR 
Table 1 Characteristics of BCC and sCC cases and population controls
Variable Characteristics of cases with BCC   
and population controls
Characteristics of cases with 
SCC and population controls
Cases (%) 
n = 69,506
Controls (%) 
n = 347,316
Cases (%) 
n = 11,526
Controls (%) 
n = 57,603
gender 
  Female 
  Male
 
32,843 (47) 
36,663 (53)
 
164,092 (47) 
183,224 (53)
 
4431 (38) 
7095 (62)
 
22,147 (38) 
35,456 (62)
Hip fracture 1930 (3) 10,914 (3) 658 (6) 3034 (5)
Age, median (range), years 69 (40–104) 69 (40–104) 78 (40–106) 78 (40–106)
 # 65 
  65–80 
  80+
27,881 (40) 
29,371 (42) 
12,254 (18)
139,252 (40) 
146,801 (42) 
61,263 (18)
1900 (16) 
4999 (43) 
4627 (40)
9487 (16) 
24,987 (43) 
23,129 (40)
Location 
  Head and neck 
  Body 
  Multiple sites 
  no registration
 
33,297 (48) 
15,362 (22) 
19,909 (29) 
938 (1)
 
166,348 (48)a 
76,755 (22)a 
99,489 (29)a 
4688 (1)a
 
6570 (57) 
2782 (24) 
1963 (17) 
211 (2)
 
32,832 (57)a 
13,905 (24)a 
9812 (17)a 
1054 (2)a
Socioeconomic status
Occupational level
  not in the work force 
  Unemployed 
  Below an executive position 
  superior or executive position 
  Missing information
27,387 (39) 
2143 (3) 
16,933 (24) 
18,256 (26) 
4820 (7)
142,384 (41) 
12,248 (4) 
88,524 (25) 
80,236 (23) 
23,924 (7)
6715 (58) 
239 (2) 
1611 (14) 
2131 (18) 
830 (7)
33,462 (58) 
1234 (2.0) 
7996 (14) 
10,986 (19) 
4146 (7)
Educational level
  no higher education 
  short-medium academic education (1–4 years) 
  Long academic education (.4 years) 
  Missing information
19,346 (28) 
16,869 (24) 
11,235 (16) 
22,056 (32)
117,306 (34) 
75,690 (22) 
40,634 (12) 
113,686 (33)
2797 (24) 
1722 (15) 
925 (8) 
6082 (53)
14,193 (25) 
8399 (14) 
4329 (7) 
30,839 (53)
income
  Lowest quartile 
  second lowest quartile 
  second highest quartile 
  Highest quartile 
  Missing information
14,091 (23) 
15,083 (23) 
15,501 (22) 
19,606 (28) 
5225 (8)
81,362 (23) 
80,844 (23) 
78,954 (23) 
77,966 (22) 
28,190 (8)
2497 (22) 
2583 (22) 
2664 (23) 
2905 (25) 
877 (8)
13,473 (23) 
13,439 (23) 
13,220 (23) 
13,034 (23) 
4594 (8)
Marital status
  Divorced/widower 
  never married 
  Married/cohabiting 
  Missing information
20,521 (30) 
4237 (6) 
39,722 (57) 
5026 (7)
107,065 (31) 
25,115 (7) 
187,656 (54) 
27,480 (8)
4048 (35) 
654 (6) 
5369 (47) 
1455 (13)
20,632 (35) 
3722 (6) 
25,889 (45) 
7517 (13)
Note: aCorresponding controls gender-matched and age-matched to the BCC cases with the specific tumor site. 
Abbreviations: BCC, basal cell carcinoma; sCC, squamous cell carcinoma.
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of 0.77 (95% CI 0.69–0.86, Table 3). Risk estimates stratified 
by gender and age were virtually the same in all strata.
History of hip fracture and risk of sCC
The prevalence of a previous hospitalization for hip fracture 
was 657 (5.7%) among SCC patients and 3047 (5.3%) in 
the control group (Table 4). The corresponding adjusted 
OR for SCC was 1.07 (95% CI, 0.98–1.17) among patients 
with a history of hip fracture. We found that the prevalence 
of a history of hip fracture was dependent of tumor location 
(P , 0.01). Stratified by location, the number of patients 
with a history of hip fracture was 422 (6.4%) among SCC 
patients with head and neck tumors and 1874 (5.7%) among 
their controls, corresponding to an adjusted OR of 1.11 
(95% CI 0.99–1.24). Among patients with trunk/extremities 
tumors and their controls, the numbers were 142 (5.1%) and 
652 (4.7%), respectively, corresponding to an adjusted OR 
of 1.09 (95% CI 0.90–1.33). Among patients with tumors at 
multiple sites and among their controls, the numbers were 
81 (4.1%) and 440 (4.5%), respectively, corresponding to 
Table 2 A history of selected chronic diseases among BCC and sCC cases and their population controls
Variable Characteristics of cases with BCC   
and population controls
Characteristics of cases with 
SCC and population controls
Cases (%) 
n = 69,506
Controls (%) 
n = 347,316
Cases (%) 
n = 11,526
Controls (%) 
n = 57,760
nondiabetic endocrine disorders 1091 (2) 5,435 (2) 198 (2) 902 (2)
Diabetes types 1 and 2 2095 (3) 12,666 (4) 561 (5) 2559 (4)
gastrointestinal disorders 484 (1) 1756 (1) 79 (1) 305 (1)
Leukemia and lymphoma 650 (1) 1613 (–) 310 (3) 338 (1)
Connective tissue diseases 1909 (1) 8261 (2) 473 (4) 1,670 (3)
Alcohol abuse 881 (1) 5905 (2) 175 (2) 815 (1)
Chronic pulmonary diseases 3313 (5) 17,432 (5) 800 (7) 3632 (6)
neurological disorders with increased risk of fall 3233 (5) 15,901 (5) 766 (7) 3235 (6)
Dementia 539 (1) 3761 (1) 215 (2) 1,156 (2)
Congestive heart failure 2191 (3) 11,706 (3) 812 (7) 3356 (6)
Cerebrovascular diseases 4103 (6) 21,912 (6) 1182 (10) 5708 (10)
solid cancer except skin cancers 4827 (7) 20,600 (6) 1059 (9) 4427 (8)
Malignant melanoma 696 (1) 1302 (–) 118 (1.0) 244 (0.4)
Chronic renal diseases 1268 (–) 384 (1) 245 (2) 297 (1)
Abbreviations: BCC, basal cell carcinoma; sCC, squamous cell carcinoma.
Table 3 Odds ratios for BCC among cases with a history of hip fracture
Previous hip fracture among cases   
and their controls
OR for BCC
Cases 
n (%)
Controls 
n (%)
Crude OR 
(95% CI)
Adjusted ORa 
(95% CI)
Total 1930 (2.8) 10,914 (3.1) 0.87 (0.83–0.92) 0.90 (0.85–0.94)
Stratified by localization
  Head and neck tumors 
  Trunk/extremities 
  Multiple sites 
  Unknown localization
1158 (3.5) 
334 (2.2) 
404 (2) 
34 (4)
6044 (3.6) 
2019 (2.6) 
2684 (3) 
167 (4)
0.95 (0.89–1.02) 
0.81 (0.72–0.92) 
0.74 (0.66–0.82) 
1.02 (0.69–1.51)
0.96 (0.90–1.02) 
0.85 (0.75–0.96) 
0.77 (0.69–0.86) 
1.07 (0.72–1.60)
Stratified by age (years)
 # 65 
  66–80 
  80+
107 (–) 
648 (2) 
1175 (10)
594 (–) 
3777 (3) 
6543 (11)
0.90 (0.73–1.10) 
0.85 (0.78–0.93) 
0.88 (0.83–0.94)
0.97 (0.79–1.09) 
0.88 (0.80–0.95) 
0.90 (0.84–0.97)b
Stratified by gender
  Male 
  Female
476 (2) 
1454 (4)
2846 (2) 
8068 (4)
0.83 (0.75–0.92) 
0.89 (0.84–0.94)
0.87 (0.79–0.96) 
0.91 (0.86–0.97)
Notes: aAdjusted for occupational level, income, marital status, nondiabetic endocrine diseases, diabetes, gastrointestinal disorders, leukemia and lymphoma, connective 
tissue diseases, alcohol abuse, chronic pulmonary, neurological diseases, dementia, congestive heart diseases, solid cancer (except skin cancer), malignant melanomas, cancer, 
and chronic renal disease; boccupational level was excluded in the adjusted analyses in the 80+ stratum. 
Abbreviations: BCC, basal cell carcinoma; CI, confidence interval; OR, odds ratio.
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an OR of 0.94 (95% CI 0.73–1.21), Table 4). Risk estimates 
stratified by gender were virtually the same.
Discussion
Our results suggest an inverse association between a 
  history of hip fracture and the risk of BCC. This was most 
  pronounced for tumors located on the trunk, extremities, and 
at multiple sites, which are markers of intermittent high sun 
exposure to large body surfaces, resulting in more vitamin D 
synthesis;31 the larger the body surface area exposed to the 
sun, the higher the synthesis of vitamin D.31
Our results suggest an increased risk of SCC in patients 
with a history of hip fractures. However, stratified by   location, 
the OR for tumors on the trunk, extremities, and at multiple 
sites were lower than for head and neck tumors.   Factors 
other than sun exposure, eg, smoking, chronic   diseases, 
and immunosuppression, play a more significant role in the 
pathogenesis of SCC than of BCC,10,12–14 which may explain 
why we did not find a reduced risk of SCC among patients 
with a prior history of hip fracture.
Sun exposure resulting in vitamin D synthesis may 
explain the link between a reduced risk of hip fracture3,5,20 
and an elevated risk of skin cancer.7 Our results are consis-
tent with the finding of self-reported high sun exposure being 
associated with a lower hip fracture risk.20,21 Our findings are 
also consistent with the reported higher prediagnostic serum 
25(OH)D levels associated with an increased risk of subse-
quent BCC,22 and the Tasmanian study reporting a reduced 
risk of prior nonmelanoma skin cancer in a fracture cohort.24 
However, variables of importance for the risk of hip frac-
ture were not taken into account in this study. Our study 
extends previous research by addressing the association 
while accounting for a wide range of covariates, includ-
ing   socioeconomic status and chronic diseases. Using 
nonmelanoma skin cancer patients as a measure of high 
sun exposure, the recall bias of self-reporting measures of 
sunlight exposure is avoided. In addition, we stratified our 
analyses by tumor location as a marker of sun exposure. Our 
results are inconsistent with the inverse association between 
25(OH)D levels and nonmelanoma skin cancer found in 
elderly men. However, as the authors of the study suggest, 
their findings may be due to sun avoidance behaviors after 
their diagnosis of nonmelanoma skin cancer, because they 
measured 25(OH)D levels at baseline and recorded a   history 
of skin cancer at baseline or five years after baseline. We 
investigated the association prior to the diagnosis of skin 
cancer.
In our study, we lacked information on patterns of sun 
exposure in patients with BCC and SCC. It is possible that 
different sun exposure patterns prior to development of BCC 
and SCC may explain the difference in association between 
prior hip fracture and risk of BCC and SCC, respectively. 
Intermittent and regular sun exposure of unprotected skin is 
the best way to increase vitamin D accumulation,6 but is also 
associated with development of BCC.8
In contrast, cumulative prolonged sun exposure of unpro-
tected skin associated with development of SCC10 does not 
lead to more vitamin D accumulation, because the amount 
Table 4 Odds ratios for sCC among cases with a history of hip fracture
Previous hip fracture among cases   
and their controls
OR for SCC
Cases 
n (%)
Controls 
n (%)
Crude OR 
(95% CI)
Adjusted ORa 
(95% CI)
Total 657 (6) 3047 (5) 1.09 (1.00–1.20) 1.07 (0.98–1.17)
Stratified by localization
  Head and neck tumors 
  Trunk/extremities 
  Multiple sites 
  Unknown localization
422 (6) 
142 (5) 
81 (4) 
12 (6)
1874 (6) 
652 (5) 
440 (5) 
68 (6)
1.14 (1.02–1.28) 
1.10 (0.91–1.33) 
0.91 (0.71–1.17) 
0.87 (0.45–1.67)
1.11 (0.99–1.24) 
1.09 (0.90–1.33) 
0.94 (0.73–1.21) 
0.82 (0.42–1.61)
Stratified by age (years)
 , 65 
  65–80 
  .80
10 (–) 
126 (3) 
521 (11)
39 (–) 
662 (3) 
2346 (10)
1.28 (0.64–2.58) 
0.95 (0.78–1.16) 
1.13 (1.02–1.26)
1.05 (0.50–2.20) 
0.92 (0.75–1.12) 
1.14 (1.03–1.27)b
Stratified by gender
  Male 
  Female
222 (3) 
435 (10)
1048 (3) 
1999 (9)
1.07 (0.92–1.24) 
1.11 (0.99–1.24)
1.03 (0.89–1.20) 
1.09 (0.98–1.23)
Notes: aAdjusted for occupational level, income, marital status, nondiabetic endocrine diseases, diabetes, gastrointestinal disorders, leukemia and lymphoma, connective 
tissue diseases, alcohol abuse, chronic pulmonary diseases, neurological diseases, dementia, congestive heart diseases, solid cancer (except skin cancer), malignant melanomas, 
cancer, and chronic renal disease; boccupational level was excluded in the adjusted analyses in the 80+ stratum. 
Abbreviations: BCC, squamous cell carcinoma; CI, confidence interval; OR, odds ratio.
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of previtamin D that can form in the skin is limited, and the 
ability to produce previtamin D is dependent on skin pig-
mentation (ie, the more pigmentation, the lower the amount 
of previtamin D synthesized per dose of ultraviolet B).6,38 In 
addition, vitamin D itself is photolabile and can be broken 
down by sunlight.39,40 A limitation of our study is a lack 
of information on lifestyle confounders, such as   smoking, 
obesity, and physical activity. However, we were able to 
adjust for chronic pulmonary disease as a proxy measure 
for smoking.
Earlier findings from Jensen et al support our findings. 
They reported better survival among BCC patients, showing 
reduced cause-specific mortality from cardiovascular disease, 
chronic pulmonary disease, and diabetes mellitus among 
patients with BCC, the diseases against which vitamin D is 
suggested to be protective.18,41 In contrast, Jensen et al found 
increased mortality among SCC patients compared with the 
general population, emphasizing differences in the clinical 
course of BCC and SCC.
A limitation of the study is lack of information regarding 
medication, which precludes us from adjusting for 
medication to treat osteoporosis, which may have influenced 
our results by decreasing fracture risk. Further, we were 
unable to adjust for immunosuppressive medication increas-
ing the risk of nonmelanoma skin cancer, especially SCC. 
Selection of cases and controls might have introduced some 
selection bias in our design. However, a major strength of our 
study was selection of controls from the general population, 
providing an unbiased control group.42 Another limitation 
is possible under-registration or under-ascertainment of 
nonmelanoma skin cancer due to the favorable prognosis of 
nonmelanoma skin cancer.43 We cannot rule out that this was 
also influenced by the presence of a history of hip fracture or 
coexistent chronic disease. If patients with chronic disease 
have more frequent contact with physicians, this could lead 
to better ascertainment and registration of nonmelanoma skin 
cancer in these patients. However, under-ascertainment of 
nonmelanoma skin cancer in patients with chronic disease 
could also occur, due to medical attention being focused on 
the more serious coexistent disease. Both scenarios would 
introduce bias due to systematic differences in characteris-
tics between those who are selected for the study and those 
not selected.44 The first scenario would skew the data on 
nonmelanoma skin cancer patients having poorer health, 
resulting in underestimation of the overall effect of a his-
tory of hip fracture on nonmelanoma skin cancer risk. The 
second scenario would skew the data on nonmelanoma skin 
cancer patients towards those with better health, leading to 
potential overestimation of the effect.44 However, the finding 
of a more pronounced inverse association between a history 
of hip fractures and risk of BCC in patients with tumors on 
trunk/extremities or at multiple sites cannot be explained 
by this possible bias.
An advantage of our study is the use of prospectively 
  collected routine data on discharge diagnoses from the 
  Danish National Patient Registry, thus avoiding recall bias. 
The Danish National Patient Registry contains data on 99.4% 
of all discharges and outpatient clinic visits from Danish 
nonpsychiatric hospitals.42 Furthermore, we obtained high 
quality information on socioeconomic status among all non-
melanoma skin cancer cases and their controls from Statistics 
Denmark, which gathers information on socioeconomic 
status variables mainly from tax authorities and the Civil 
Registration System in Denmark, with high validity.
In conclusion, our results indicate that patients with a 
history of hip fracture have a reduced the risk of BCC, but 
not of SCC. The correlation between a history of skin cancer 
and location of tumor suggests that sun exposure, resulting 
in vitamin D synthesis, may explain the link between the 
two diseases.
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Covariates with corresponding iCD-8 and iCD-10 codes
ICD-8 ICD-10
nondiabetic endocrine disorders 
• Adrenal insufficiency 
• Cushing’s syndrome 
• Thyrotoxicosis 
• Hyperparathyroidism
 
255.10–255.19 
258.00–258.19 
242 
252.00–252.09
 
E27.1–E27.4 
E24 
E05 
E21
Diabetes types 1 and 2 249; 250 E10; E11
gastrointestinal disorders 
• Celiac disease 
• Inflammatory bowel disease
 
269.00 
563.01; 563.19; 569.04
 
K90.0 
K50.1; K50.8; K50.9; K51.0–51.3
Leukemia and lymphoma 204–207; 200–203; 275.59 C91–C95; C81–C85; C88; C90; C96
Connective tissue diseases 712; 716; 734; 446; 135.99 M05; M06; M08; M09; M30; M31; 
M32; M33; M34; M35; M36; D86
Alcohol abuse 303 F10
Chronic pulmonary diseases 490–493; 515–518 J40–J47; J60–J67; J68.4; J70.1; 
J70.3; J84.1; J92.0; J96.1; J98.2; J98.3
neurological disorders with increased risk of falls 330–333, 
340–343, 344, 345, 
353–355, 348; (040–044)
g10–g13; g20–g26 
g30–g32, g35–g37, g40;  
g41, g45–g46; g55–g63, 
g70–g73, g80–g82, (A80–A82)
Dementia 290.09–290.19; 293.09 F00–F03; F05.1
Congestive heart failure 427.09; 427.10; 427.11; 427.19;  
428.99; 782.49
i50; i11.0; i13.0; i13.2
Cerebrovascular disease 430–438 i60-i69; g45; g46
solid cancer except skin cancers 140–194 (except 172 and 173) C00–C75 (except C43 and C44)
Malignant melanoma 172 C43
Chronic renal diseases 792 n18 n19
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